We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$27.1B
AUM Growth
+$1.07B
Cap. Flow
+$498M
Cap. Flow %
1.84%
Top 10 Hldgs %
21.61%
Holding
3,481
New
179
Increased
1,545
Reduced
1,498
Closed
172
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRNY icon
2826
Kearny Financial
KRNY
$604M
$257K ﹤0.01%
41,734
+14,741
+55% +$84.3K
LNN icon
2827
Lindsay Corp
LNN
$1.16B
$257K ﹤0.01%
+2,095
New +$244K
OCFC icon
2828
OceanFirst Financial
OCFC
$1.87B
$257K ﹤0.01%
16,157
+3,354
+26% +$50.7K
AQN icon
2829
Algonquin Power & Utilities
AQN
$4.43B
$256K ﹤0.01%
43,645
-10,678
-20% -$66.2K
BSMR icon
2830
Invesco BulletShares 2027 Municipal Bond ETF
BSMR
$347M
$256K ﹤0.01%
10,898
+46
+0.4% +$1.08K
CCK icon
2831
Crown Holdings
CCK
$13B
$256K ﹤0.01%
3,436
-842
-20% -$67.9K
ITRI icon
2832
Itron
ITRI
$4.41B
$256K ﹤0.01%
+2,583
New +$260K
PFS icon
2833
Provident Financial Services
PFS
$3.26B
$256K ﹤0.01%
17,814
-1,111
-6% -$16.1K
PRNT icon
2834
The 3D Printing ETF
PRNT
$65.3M
$255K ﹤0.01%
12,981
-3,139
-19% -$65.5K
PLAB icon
2835
Photronics
PLAB
$1.99B
$254K ﹤0.01%
10,291
-16,347
-61% -$443K
PSN icon
2836
Parsons
PSN
$5.05B
$254K ﹤0.01%
3,108
+363
+13% +$28.5K
BMRN icon
2837
BioMarin Pharmaceuticals
BMRN
$13.4B
$253K ﹤0.01%
3,070
+524
+21% +$43.6K
GALT icon
2838
Galectin Therapeutics
GALT
$334M
$253K ﹤0.01%
112,130
-9,011
-7% -$27.4K
MBC icon
2839
MasterBrand
MBC
$1.89B
$253K ﹤0.01%
17,221
+1,905
+12% +$31.5K
NULC icon
2840
Nuveen ESG Large-Cap ETF
NULC
$73.9M
$253K ﹤0.01%
5,773
+16
+0.3% +$681
AWAY icon
2841
Amplify Travel Tech ETF
AWAY
$32.3M
$252K ﹤0.01%
12,915
-857
-6% -$17.1K
INDB icon
2842
Independent Bank
INDB
$4.05B
$252K ﹤0.01%
4,978
-2,912
-37% -$146K
FIVE icon
2843
Five Below
FIVE
$13.4B
$251K ﹤0.01%
2,307
-535
-19% -$74.1K
FPF
2844
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.09B
$251K ﹤0.01%
13,649
+1,054
+8% +$18.5K
HOPE icon
2845
Hope Bancorp
HOPE
$1.83B
$251K ﹤0.01%
23,328
+4,413
+23% +$46.5K
PPLI
2846
People Inc
PPLI
$2.99B
$251K ﹤0.01%
6,530
+748
+13% +$30.9K
GNW icon
2847
Genworth Financial
GNW
$3.78B
$250K ﹤0.01%
41,467
-300
-0.7% -$1.87K
SHAK icon
2848
Shake Shack
SHAK
$2.93B
$250K ﹤0.01%
2,780
+7
+0.3% +$683
SNV
2849
DELISTED
Synovus
SNV
$250K ﹤0.01%
6,217
-262
-4% -$9.93K
UHAL icon
2850
U-Haul Holding Co
UHAL
$14.4B
$250K ﹤0.01%
4,053
-328
-7% -$21.3K

Similar funds

Cambridge Investment Research Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Cambridge Investment Research Advisors held 3,481 positions worth $27.1B, up 4.1% from $26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambridge Investment Research Advisors's Q2 2024 filing shows 179 new, 1,545 increased, 1,498 reduced and 172 closed positions. Its largest new stake was Sila Realty Trust: 733,789 shares worth $15.5M. The largest sale was Invesco QQQ Trust, an estimated $99.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2024 buy was Sila Realty Trust: 733,789 shares worth $15.5M.
  • Cambridge Investment Research Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2024, an estimated $77.4M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $99.4M.
  • Cambridge Investment Research Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.55M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2024.
  • Cambridge Investment Research Advisors opened 179 new positions and closed 172 in Q2 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $27.1B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.